RVL Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 05/22/2024

Stock Rating
6
Price Target
$1.60
Consensus
Upside
0.00%
Analysts
0
Stock Rating
6
Upside
0.00%
Analysts
0
Price Target
$1.60

RVL Pharmaceuticals Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for RVL Pharmaceuticals were recently set by distinguished experts, with an average mark of $1.60. If it reached this goal, it would represent a potential upside of approximately 100% from the previous closing price in February, 2024. The high end is $1.60, and the low is $1.60. If you are interested in RVLP.Q stock, it is important to also consider its competitors.

$1.60

0.00% Upside

RVL Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last zero years, RVL Pharmaceuticals's Price has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 1 analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is Fair Valueof $0.00, which would mean a seven-year growth forecast of 100.00%.

2024 Fair Value Forecast
$0.00
2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

RVL Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

2024 Rev Forecast
$0.05B
2025 Rev Forecast
$0.08B
2026 Rev Forecast
$0.05B
2027 Rev Forecast
$0.06B
2028 Rev Forecast
$0.06B
2029 Rev Forecast
$0.07B
2030 Rev Forecast
$0.06B

RVL Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

RVL Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

RVL Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

RVL Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

2024 EBIT Forecast
$-33780000.00
2025 EBIT Forecast
$-18550000.00
2026 EBIT Forecast
$-33779550.00
2027 EBIT Forecast
$-32869754.12
2028 EBIT Forecast
$-37228283.52
2029 EBIT Forecast
$-30523469.66
2030 EBIT Forecast
$-31849205.69

RVL Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last zero years, RVL Pharmaceuticals's EPS has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 1 analysts predict EPS of $-0.42, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is EPSof $-0.29, which would mean a seven-year growth forecast of 100.00%.

2024 EPS Forecast
$-0.42
2025 EPS Forecast
$-0.26
2026 EPS Forecast
$-0.28
2027 EPS Forecast
$-0.24
2028 EPS Forecast
$-0.29
2029 EPS Forecast
$-0.29
2030 EPS Forecast
$-0.29